Metabolic actions of fibroblast growth factor 21
- PMID: 22732636
- DOI: 10.1097/MOP.0b013e3283557d22
Metabolic actions of fibroblast growth factor 21
Abstract
Purpose of review: FGF21 has emerged as a hormone involved in energy homeostasis. A large number of recent reports have expanded the role of FGF21 from a response factor to prolonged fasting to a key hormone that regulates free fatty acid (FFAs) levels. The therapeutic role of recombinant human FGF21 for type 2 diabetes and dyslipidemia is under study.
Recent findings: Recent evidence suggests that supraphysiological concentrations of FFAs induce FGF21 secretion (i.e., starvation and intense physical activity) through the peroxisome proliferator-activated receptor alpha (PPARα) pathway. The rise in FGF21 levels is aimed at improving energy production (ketogenesis) and utilization (oxidation) of FFAs. FGF21 increment may protect against chronic exposure to high concentrations of FFAs, which causes lipotoxicity in muscle, pancreas, and liver. In addition, FGF21 induces appetite and inhibits growth, probably as part of the adaptive starvation response. The autocrine function of FGF21 in adipose tissue increases PPARγ activity and glucose uptake. Increased plasma FGF21 levels have been found in insulin resistance states in humans. However, the reason for this rise in FGF21 values is still under study.
Summary: We propose that FGF21 serves as a defense mechanism against supraphysiological concentrations of FFAs. In addition, FGF21 might have a therapeutic indication in humans.
Similar articles
-
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.Cell Metab. 2007 Jun;5(6):415-25. doi: 10.1016/j.cmet.2007.05.003. Cell Metab. 2007. PMID: 17550777
-
Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.Clin Endocrinol (Oxf). 2013 Apr;78(4):489-96. doi: 10.1111/cen.12095. Clin Endocrinol (Oxf). 2013. PMID: 23134073 Review.
-
Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARalpha and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor.J Endocrinol. 2010 Apr;205(1):37-47. doi: 10.1677/JOE-09-0405. Epub 2010 Jan 22. J Endocrinol. 2010. PMID: 20097691
-
PPARalpha is a key regulator of hepatic FGF21.Biochem Biophys Res Commun. 2007 Aug 24;360(2):437-40. doi: 10.1016/j.bbrc.2007.06.068. Epub 2007 Jun 21. Biochem Biophys Res Commun. 2007. PMID: 17601491
-
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.Med Res Rev. 2016 Jul;36(4):672-704. doi: 10.1002/med.21390. Epub 2016 Mar 31. Med Res Rev. 2016. PMID: 27031294 Review.
Cited by
-
Hypoxia-Induced Adipose Lipolysis Requires Fibroblast Growth Factor 21.Front Pharmacol. 2020 Aug 14;11:1279. doi: 10.3389/fphar.2020.01279. eCollection 2020. Front Pharmacol. 2020. PMID: 32922298 Free PMC article.
-
Loss of FGF21 in diabetic mouse during hepatocellular carcinogenetic transformation.Am J Cancer Res. 2015 Apr 15;5(5):1762-74. eCollection 2015. Am J Cancer Res. 2015. PMID: 26175944 Free PMC article.
-
The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK/Sirt1/PGC-1α signaling.Endocrinology. 2015 Mar;156(3):1156-70. doi: 10.1210/en.2014-1619. Epub 2015 Jan 5. Endocrinology. 2015. PMID: 25560828 Free PMC article.
-
FGF21 functions as a sensitive biomarker of APAP-treated patients and mice.Oncotarget. 2017 Jul 4;8(27):44440-44446. doi: 10.18632/oncotarget.17966. Oncotarget. 2017. PMID: 28591702 Free PMC article.
-
White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice.PLoS One. 2016 Feb 25;11(2):e0149670. doi: 10.1371/journal.pone.0149670. eCollection 2016. PLoS One. 2016. PMID: 26914024 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials